<?xml version='1.0' encoding='utf-8'?>
<document id="24365983"><sentence text="Severe decrease of cyclosporine levels in a heart transplant recipient receiving the direct thrombin inhibitor argatroban."><entity charOffset="19-31" id="DDI-PubMed.24365983.s1.e0" text="cyclosporine" /><entity charOffset="111-121" id="DDI-PubMed.24365983.s1.e1" text="argatroban" /><pair ddi="false" e1="DDI-PubMed.24365983.s1.e0" e2="DDI-PubMed.24365983.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24365983.s1.e0" e2="DDI-PubMed.24365983.s1.e1" /></sentence><sentence text="This case report is about a suspected interaction between argatroban, a direct thrombin inhibitor, and cyclosporine, which occurred in a 60-year-old patient after a second heart transplantation"><entity charOffset="58-68" id="DDI-PubMed.24365983.s2.e0" text="argatroban" /><entity charOffset="103-115" id="DDI-PubMed.24365983.s2.e1" text="cyclosporine" /><pair ddi="false" e1="DDI-PubMed.24365983.s2.e0" e2="DDI-PubMed.24365983.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24365983.s2.e0" e2="DDI-PubMed.24365983.s2.e1" /></sentence><sentence text=" We explored 4 possible mechanisms of interaction, which are an analytical interference, an idiopathic hemodilution, an increase of renal and hepatic clearance, and a metabolic drug-drug interaction" /><sentence text="" /></document>